Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)

Sponsor
Kyberg Vital GmbH (Industry)
Overall Status
Completed
CT.gov ID
NCT01425983
Collaborator
(none)
80
1
2
15
5.3

Study Details

Study Description

Brief Summary

Psychosocial stress leads to altered neuroendocrine functions, such as serotonergic dysfunction, as well as alterations of the autonomic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis activity resulting in an imbalance between inhibitory and excitatory neurotransmitters. Clinical consequences include, inter alia, neurovegetative disorders, higher resting heart rate, hypertension, depressive symptoms, sleep disturbances, irregular body-weight changes, and insulin resistance. Poor dietary intake of the essential amino acid L-tryptophane as a precursor to 5-hydroxytryptamine (HT, serotonin) increases sensitivity to stress.

It is therefore the investigators hypothesis that daily oral administration of an amino acid mixture (dosage 3.8 g/day) with micronutrients specifically designed to decrease neurovegetative disorders will target these neuroendocrine and metabolic alterations in adults with psychosocial stress. The principal endpoints will be a decrease in points in the psychological-neurological questionnaire (PNF).

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: amino acid composition (asn01)
  • Other: Placebo
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Dietary Intervention of Stress-Induced Neurovegetative Disorders in Men and Women With a Specific Amino Acid Composition With Micronutrients
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
May 1, 2012
Actual Study Completion Date :
Jun 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: amino acid composition (asn01)

Dietary supplement: specific amino acid composition with micronutrients

Dietary Supplement: amino acid composition (asn01)
Amino acid composition with micronutrients, once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water. Duration: 12 weeks
Other Names:
  • Brand name: aminoplus neurostress
  • Placebo Comparator: Sugar powder

    Placebo contains no amino acids and no micronutrients and is identical in appearance and solution properties.

    Other: Placebo
    Placebo; once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water. Placebo contains no amino acids and micronutrients and is identical in appearance and solution properties. Duration: 12 weeks

    Outcome Measures

    Primary Outcome Measures

    1. Psychological neurological questionnaire (PNF) [12-week dietary intervention]

      Pre-post intervention changes in total number of points PNF

    Secondary Outcome Measures

    1. Psychological neurological questionnaire (PNF) [12-week dietary intervention]

      Pre-post improvement in total number of points from the psychological-neurological questionnaire (PNF) about 10 Points or more

    2. Salivary cortisol concentration (30 minutes after waking in the morning) [12-week dietary intervention]

      Absolute difference between cortisol concentration at baseline and 12 weeks

    3. Salivary cortisol concentration (in the evening between 8 and 10 pm, 2 hours after dinner) [12-week dietary intervention]

      Absolute difference between cortisol concentration at baseline and 12 weeks

    4. Serotonin concentration in blood [12-week dietary intervention]

      Absolute difference between serotonin concentration at baseline and 12 weeks

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age: 18-65 Years

    • Psychological-Neurological Questionnaire (PNF): 30 - 50 Points

    Exclusion Criteria:
    • Age: < 18 and > 65 Years

    • Psychological neurological questionnaire (PNF): < 30 and > 50 Points

    • Resting heart rate: < 70/min

    • Supplementation with dietary supplements or drugs which contains amino acids, vitamins and other micronutrients

    • Therapy with antipsychotic drugs such as tranquilizer, antidepressants

    • acute and chronic diarrhea

    • Psychological-neurological or psychiatric therapy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cardiological Outpatient Practice Elke Parsi, MD Berlin Germany 13053

    Sponsors and Collaborators

    • Kyberg Vital GmbH

    Investigators

    • Principal Investigator: Christine Metzner, Professor MD, Bonn Education Association for Dietetics r.A., Cologne, Germany

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Doris Meister, Doris Meister, Sponsor-Investigator, Kyberg Vital GmbH
    ClinicalTrials.gov Identifier:
    NCT01425983
    Other Study ID Numbers:
    • Kyberg-02
    First Posted:
    Aug 30, 2011
    Last Update Posted:
    Sep 7, 2015
    Last Verified:
    Sep 1, 2015
    Keywords provided by Doris Meister, Doris Meister, Sponsor-Investigator, Kyberg Vital GmbH
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 7, 2015